Voltaren, Voltaren-XR, Solaraze
Classifications: central nervous system agent; analgesic, antipyretic; nsaid
Pregnancy Category: B
Assessment & Drug Effects
- Monitor for therapeutic effectiveness. Up to 3 wks may be needed for beneficial effects with rheumatoid arthritis or osteoarthritis.
- Lab tests: Periodic liver function, serum uric acid concentrations Hct, PT/INR, and blood glucose.
- Observe and report signs of bleeding (e.g., petechiae, ecchymoses, bleeding gums, bloody or black stools, cloudy or bloody urine).
- Monitor BP for hypertension and blood sugar for hyperglycemia.
- Monitor diabetics closely for loss of diabetic control.
- Monitor for increased serum sodium and potassium in patients receiving potassium-sparing diuretics.
- Monitor weight and report gains greater than 1 kg (2 lb)/24 h.
- Monitor for signs and symptoms of GI irritation and ulceration.
Patient & Family Education
- Do not lie down for 15–30 min after taking medicine to decrease esophageal irritation.
- Discontinue use with onset of ringing or buzzing in the ears, impaired hearing, dizziness, GI discomfort, or bleeding and notify physician.
- Do not take aspirin or other OTC analgesics without permission of the physician.
- Avoid alcohol or other CNS depressants.
- Do not drive or engage in other potentially hazardous activities until reaction to drug is known.
- Note: Diabetics need to monitor blood glucose carefully for loss of glycemic control.
- Do not breast feed while taking this drug.